AHB(SH:688639) Zheng Quan Zhi Xing·2025-09-04 16:18Core Viewpoint - Anhui Huaheng Biological Technology Co., Ltd. plans to issue H-shares and apply for listing on the Hong Kong Stock Exchange, necessitating revisions and formulations of internal governance systems to comply with relevant regulations [1][2]. Group 1: Governance System Revisions - The company held its 23rd meeting of the 4th Board of Directors on September 4, 2025, where it approved the proposal to revise and formulate internal governance systems applicable after the issuance of H-shares [1]. - The governance systems to be revised or formulated include a total of 18 items, with the first 6 requiring approval from the shareholders' meeting and the remaining 12 approved by the Board of Directors [2]. - The revised governance system drafts were disclosed on the Shanghai Stock Exchange website on the same day as the board meeting [2]. Group 2: Implementation and Authorization - The revised governance systems will take effect from the date of the company's H-share listing, while the existing governance systems will remain in effect until further revisions are made [2]. - The shareholders' meeting is requested to authorize the Board of Directors and/or its authorized personnel to make adjustments and modifications to the approved documents as necessary, based on domestic and foreign laws and regulations [2].